Factor V Leiden is not commonly associated with idiopathic portal vein thrombosis in Southern India

Indian Journal of Gastroenterology

Volumn 25, Issue 3, 2006, Pages 140-142

  Koshy, Abraham ^a,b   Jeyakumari, Mary ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b Lakeshore Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; HUMAN; IDIOPATHIC DISEASE; INDIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PORTAL VEIN THROMBOSIS; PROTEIN DETERMINATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INDIA; INFANT; MALE; MESENTERIC VEINS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PORTAL VEIN; SPLENIC VEIN; VENOUS THROMBOSIS;

EID: 33748296111     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
2. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997;43:1678-83.
3. Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. Am J Med 1992;92:173-82.
4. Koshy A, Deshpande JV, Bahl CM. Clinical differentiation between portal vein thrombosis (PVT), non-cirrhotic portal fibrosis (NCPF) and cirrhosis by discriminant analysis. Indian J Gastroenterol 1984;3:197-8.
5. Egesel T, Buyukasik Y, Dundar SV, Gurgey A, Kirazli S, Bayraktar Y. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol 2000;30:66-71.
6. El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, et al . Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann Hematol 2004;83:712-5.
7. Gurakan F, Eren M, Kocak N, Yuce A, Ozen H, Temizel IN, et al . Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up. J Clin Gastroenterol 2004;38:368-72.
8. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, Der Meer FJ, et al . Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8.
9. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, et al . Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120:490-7.
10. Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997;40:798-800.
11. Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, et al . Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005;41:603-8.
12. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al . Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
13. Saxena R, Mohanty S, Srivastava A, Choudhry VP, Kotwal J. Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians. Eur J Haematol 1999;63:26-8.
14. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, et al . Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 2001;7:158-65.
15. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from western India. Hepatology 2001;34:666-70.
16. Shah SR, DasGupta A, Sharma A, Joshi A, Desai D, Abraham P, et al . Thrombophilic conditions in non-cirrhotic portal vein thrombosis. Indian J Gastroenterol 2005;24:205-10.
17. Leroyer C, Mercier B, Escoffre M, Ferec C, Mottier D. Factor V Leiden prevalence in venous thromboembolism patients. Chest 1997;111:1603-6.
18. Koshy A, Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol 2006;85:126-8.